Medicare has officially started covering obesity drugs for the first time through a temporary government program – and companies like Walmart and CVS Health are playing an important role for patients.
The huge shift in Medicare policy is going to open up access to millions of older Americans who previously couldn’t afford blockbuster GLP-1s from Novo Nordisk and Eli Lilly to treat obesity. But many seniors may not know about this new coverage or how to navigate its complexities, such as eligibility requirements and how it differs from traditional Medicare insurance for drugs, CNBC previously reported. ARTICLE